Performance Evaluation of LumiraDx SARS-CoV-2, Flu A/B, and RSV Tests for COVID-19 Assessment

Clinical trial NCT05268939 · COMPLETED

Trial details

NCT number: NCT05268939
Sponsor: LumiraDx UK Limited
Status: COMPLETED
Study type: OBSERVATIONAL

COVID-19 Influenza A Influenza Type B RSV Infection

Start date: 2022-01-04
Primary completion: 2022-04-25
Enrollment: 589

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.